Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 8Breast 6Genitourinary 5Tumor-Agnostic 3Other 3Lymphoid 3Thoracic 2Sarcoma 2Head & Neck 2Other hematologic neoplasm 1Gynecologic 1Endocrine 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Electroacupuncture × Thoracic × Clear all
NCT07239661 2025-11-20

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase NA Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07086300 2025-07-25

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Phase NA Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡